SOPHIA: A phase 3, randomized study of margetuximab (M) plus chemotherapy (CTX) vs trastuzumab (T) plus CTX in the treatment of patients with HER2+metastatic breast cancer (MBC) / H.S. Rugo, M.D.P.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 34:15(2016). [10.1200/JCO.2016.34.15_suppl.TPS630]
SOPHIA: A phase 3, randomized study of margetuximab (M) plus chemotherapy (CTX) vs trastuzumab (T) plus CTX in the treatment of patients with HER2+metastatic breast cancer (MBC)
G. Curigliano;
2016
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ABSTRACT126836.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
116.51 kB
Formato
Adobe PDF
|
116.51 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
